Evolus (EOLS) Gross Profit (QoQ) (2019 - 2026)
Evolus (EOLS) Gross Profit (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Evolus | 402.20 Mn | 352.41 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.53% |
| Dec 31, 2025 | 29.34% |
| Sep 30, 2025 | 1.15% |
| Jun 30, 2025 | -2.86% |
| Mar 31, 2025 | -11.36% |
| Dec 31, 2024 | 25.02% |
| Sep 30, 2024 | -10.56% |
| Jun 30, 2024 | 16.21% |
| Mar 31, 2024 | 4.46% |
| Dec 31, 2023 | 12.10% |
| Sep 30, 2023 | -0.13% |
| Jun 30, 2023 | 17.11% |
| Mar 31, 2023 | 8.25% |
| Dec 31, 2022 | 33.87% |
| Sep 30, 2022 | -4.38% |
| Jun 30, 2022 | 3.11% |
| Mar 31, 2022 | 9.97% |
| Dec 31, 2021 | 23.94% |
| Sep 30, 2021 | 2.64% |
| Jun 30, 2021 | 101.77% |